Purpose. To determine whether continuous infiltration of local anaesthetic can reduce the pain score and morphine use over 48 hours after total knee arthroplasty (TKA). Methods. 11 men and 43 women aged 50 to 82 years who underwent unilateral TKA for osteoarthritis were recruited. They were randomised into 3 groups. In group 1, 17 patients who acted as controls received patient-controlled analgesia (PCA) with intravenous morphine for 48 hours. In group 2, 16 patients received continuous infiltration of bupivacaine to the subcutaneous tissue and intra-articular space for 48 hours, in addition to PCA. In group 3, 21 patients received an intra-articular injection of local anaesthetic, followed by continuous infiltration of bupivacaine to the subcutaneous tissue and intraarticular space for 48 hours, in addition to PCA. For each patient, a visual analogue score (VAS) for pain was recorded postoperatively at 2, 4, 6, 12, 24, 36, and 48 hours. The total amount of morphine used was Surgery 2010;18(2):203-7 recorded at 24 and 48 hours. Results. Over 48 hours, the VAS for pain and morphine use was significantly higher in controls than patients in groups 2 and 3. Conclusion. Continuous infiltration of local anaesthetic into the intra-articular space and subcutaneous tissues, in addition to PCA with intravenous morphine, provides significantly more pain relief and reduces morphine use.
INTRODUCTION
Total knee arthroplasty (TKA) is associated with considerable postoperative pain. 1 Pain relief is a necessary requirement for postoperative rehabilitation. It should be multimodal and pre-emptive through a combined drug synergy effect on the central and peripheral nervous system. [2] [3] [4] [5] [6] [7] Intravenous morphine via a patient-controlled pump is usually used for pain management after TKA. However, this is associated with multiple sideeffects such as respiratory depression, drowsiness, nausea and vomiting, pruritis, reduced gut motility, and urinary retention. 1 Continuous infiltration of local anaesthetic has been shown to be efficacious and safe for cardiothoracic and abdominal surgeries and for lumbar spinal fusion. [8] [9] [10] In TKA, it can reduce the pain score and the narcotic usage for up to 24 hours. 1, [11] [12] [13] Intra-articular morphine can also reduce postoperative pain intensity and use of analgesia. 11 Nonetheless, the short half-life of bupivacaine (3.5 hours), morphine (3-5 hours) and ketorolac (3.5-9.2 hours) does not provide sustained pain relief for 48 hours. Additives with adrenaline and kenocort (triamcinalone) can prolong the effects of the local anaesthetics, but have the concern of increased risk of infection and tissue ischaemia.
14 Most studies reported the pain scores and morphine use for up to 24 hours only. We aimed to determine whether continuous infiltration of local anaesthetic can reduce the pain score and morphine use over 48 hours after TKA.
MATERIALS AND METHODS
The ethics committee of our hospital approved this study. Written informed consent was obtained from each patient. 11 men and 43 women aged 50 to 82 years who underwent unilateral TKA for osteoarthritis were recruited. Patients were excluded if they had physical status corresponding to classes III to V (according to the American Society of Anesthesiologist), had a psychiatric illness, were dependent on narcotics, or were allergic to morphine or any local anaesthetic or oral analgesic.
Four different surgeons performed the TKAs using conventional techniques. Patients were randomised into 3 groups. In group 1, 17 patients who acted as controls received patient-controlled analgesia (PCA) with intravenous morphine for 48 hours. In group 2, 16 patients received continuous infiltration of bupivacaine (4 ml of 0.25%) to the subcutaneous tissue and intra-articular space for 48 hours, in addition to PCA. In group 3, 21 patients received an intra-articular injection of local anaesthetic consisting of normal saline (50 ml), ketorolac (1 ml), morphine (10 mg) and bupivacaine (100 mg), followed by continuous infiltration of bupivacaine (4 ml of 0.25%) to the subcutaneous tissue and intra-articular space for 48 hours, in addition to PCA. Adrenaline should be omitted, as it can cause tissue necrosis leading to the blistering. Careful placement of the cannula deep in the subcutaneous tissue and the intra-articular space is crucial to prevent this complication. To reduce leakage of local anaesthetic, the amount of intra-articular injection in group 3 should be less than 72 ml, but more than 30 ml (for it to be effective).
Continuous infiltration was maintained by an elastomeric infusion pump consisting of a pressurised reservoir and a flow restricter (Fig. 1 ). Consistent delivery with no backflow was enabled through a flow regulator. The risk of infection was reduced with a bacterial filter. Delivery of the local anaesthetic was ensured by multiple serrations of the catheter delivery system. The catheter was easily removable. Bupivacaine was delivered to 2 cannulae each with one catheter placed in the intra-articular space and the other threaded into the subcutaneous tissues under the incision. One drain was inserted in the intra-articular space. It was clamped for 8 hours and then released for half an hour and then reclamped. Both the drain and infusion catheters were removed on day 2. Etoricoxib, paracetamol, and subcutaneous enoxaparin were prescribed on day 1. Continuous passive motion therapy was provided.
The visual analogue score (VAS) and somnolence score were recorded postoperatively at 2, 4, 6, 12, 24, 36, and 48 hours. Most patients complained of pain in the initial few hours and did not require morphine after 48 hours. Any side-effects of morphine (such 
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Reservoir as nausea, vomiting, giddiness, urinary retention) were also recorded. The total amount of morphine used was recorded at 24 and 48 hours. Patients were assessed by an independent physiotherapist and underwent intensive rehabilitation. Their range of knee movement was recorded daily with a goniometer. Rescue medication included dose adjustments for the PCA (morphine).
To achieve an 80% power for detecting a VAS decrease of 1.5 over the 48 hours between groups, and when the treatment standard deviation was assumed to be 1.25, a sample size of 15 per group was needed.15 The calculation took into account the Bonferroni adjustment for the significance level of 0.05 for 3 pairwise multiple comparison of groups.
Continuous data (age, weight, height, body mass index, length of hospital stay, range of knee motion on discharge, drainage from the intraarticular space) of the 3 groups were compared using the Kruskal-Wallis test. Categorical data (ethnicity, complaints) were compared using the Chi squared test. Within-and between-group outcomes were (65) 6 (35) 11 (69) 5 (31) 12 (57) The VAS over the 48 hours for all paired groups were compared using the Post-hoc Tukey HSD test.
RESULTS
There were no significant differences between the 3 groups in terms of patient age, sex, type of anaesthesia used, site of operation, length of hospital stay, range of knee motion on discharge, and side-effects of morphine usage (Table) . In group 3, the duration of the operations was significantly longer (p<0.0005), owing to the preparation for the pump and intraarticular injection of local anaesthetic. This was resolved by changing to preoperative preparation by assistants. In controls, the drainage volume decreased substantially from day 1 to 2. The half-hour release of the clamped drain every 8 hours enabled effective local anaesthetic infiltration and prevented the washout of local anaesthetic in the intra-articular space. The VAS was significantly higher in controls than patients in group 2 (p<0.0005) and group 3 (p<0.0005) over 48 hours, but not between groups 2 and 3 (p=0.931) [ Fig. 2 ]. Morphine use was significantly higher in controls than patients in group 2 (p=0.022) and group 3 (p<0.0005) over 48 hours, but not between groups 2 and 3 (p=0.482) [Fig. 3] .
No patients developed adverse effects secondary to bupivacaine overdose. The total amount of bupivacaine received by patients in groups 2 and 3 was 240 and 340 mg/day, respectively, which was well below the recommended limit of 400 mg/day. 16 No patients developed wound or deep-sited infection, despite the use of an extrinsic pump. Nonetheless, the need to change the dressing increased because of increased discharge. Four patients in groups 2 and 3 developed skin blistering owing to the superficial placement of the cannula and leakage of local anaesthetic from the intra-articular space into the subcutaneous plane.
DISCUSSION
Continuous infiltration of local anaesthetic provides additional pain relief after TKA. It can be used as an adjunct to other modalities of pain relief (such as PCA with intravenous morphine) so as to reduce the side-effects of morphine and to improve the rehabilitation.
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